SYDNEY, March 17, 2023 /PRNewswire/ -- SYMBYX, an Australian medtech company developing light therapies for intractable disease conditions, today announced the results of a Sydney Adventist Hospital ...
A new Parkinson’s disease clinical trial with patients wearing laser light helmets has shown “promising results,” as the therapy helped “improve motor function” for those facing the progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results